TheNewsRoom | Repros Therapeutics Soars on Androxal vs. Testim Study; Auxilium Shares Fall

All of these words:

The exact phrase:

None of these words:

Categories

Date

Providers

Advanced Search

Learn More

Grab Networks has a huge collection of videos from over 300 news sources. Find in-depth news, embed it to your site, and build community!

About Us
Embedding
Getting Paid
Updates

Connect

The Gallery

Bookmark

Repros Therapeutics Soars on Androxal vs. Testim Study; Auxilium Shares Fall

October 07, 2009

After the bell Wednesday, Repros Therapeutics (RPRX) announced results from an exploratory study of its Androxal treatment, designed to treat men with secondary hypogonadism who are receiving testosterone replacement treatment. Hypogonadism is a condition where the testes produce little or no hormones, and is typically treated with a topical testosterone gel.